Thomas Remer- DONALD Study Centre Dortmund, Institute of Nutrition and Food Science (IEL), University of Bonn, Dortmund, Germany
Normal function of the hypothalamic-pituitary-thyroid axis implies an increase in thyrotropin (TSH) secretion if circulating thyroxin (T4) and/or triiodothyronine (T3) fall. A fall in thyroxine does occur in moderate to severe iodine deficiency when amounts of iodine taken up and stored in the gland no longer suffice to maintain adequate hormone synthesis and secretion. Accordingly, there is overwhelming consent that severely iodine-deficient populations generally have higher serum TSH concentrations than adequately supplied populations (1).
Despite that, higher circulating TSH levels are also observable along with excessive iodine intake (2–4). Correspondingly, a number of studies found U-shaped relationships for different indicators of thyroid disorders, including thyroglobulin and TSH levels over a wide range of iodine supply from clearly deficient to excessive iodine intake (5–8).
Referring to this, Laurberg et al. reported that below iodine intake levels of around 220 μg/day rather no increased risk of subclinical hypothyroidism, i.e., of relevant elevations of TSH is present for adults (6). Zimmermann et al. (5) who examined 6–12 years old children, notified that there need be no fear of increases in the prevalence of elevated TSH or thyroglobulin levels, as long as urinary iodine concentrations (UIC) are below 300 μg/Liter in this age group.
On the other hand, there is a growing number of studies reporting increases in TSH that occur at clearly lower iodine intake or urinary iodine excretion levels (both in children and adults) than those specified by the aforementioned authors. Corresponding results have been observed in the Korean National Health and Nutrition Examination Survey 2013–2015 (9). A recent large Chinese study reported raising serum TSH concentrations already from urinary iodine concentrations of 50 μg/L upward up to around 500 μg/L in a well characterized reference population, i.e., in adults without personal or family histories of thyroid dysfunction, without visible or palpable goiter, without having different kinds of thyroid-related antibodies, and without taking any medication except estrogens (10). This finding of a TSH rise along with an increase in iodine nutrition occurring already at lower initial iodine intake levels is in line with another Chinese examination in children (11) and a Danish examination in adults (12) both comparing regions of low iodine intake (median UIC < 100 μg/L, or median 24-h iodine excretion around 50 μg/day) with regions of correspondingly higher intake and excretion levels. Additional evidence comes from observations, e.g., from Italy (13) and again from Denmark (14), describing enhancing effects of iodine fortification on population's serum TSH concentrations in populations with initial mild to moderate iodine deficiency.
Accordingly, the remarkable increases in the diagnosis of subclinical hypothyroidism (i.e., the rise in the number of exceedings of given TSH cut-offs) after iodine nutrition has improved in certain regions or populations with mild to moderate iodine deficiency (15–18), may reflect—at least in part—a consequence of an iodine rise-related right shift of the respective population's TSH distribution (19). Such a TSH right shift along with an appropriately increased iodine intake has been reported recently also for thyroid-healthy children and adolescents (20). All these findings, in turn, may explain a relevant part of the current relative large number of patients treated for hypothyroidism and receiving thyroxine, although probably not requiring thyroid hormone therapy, as has to some extent been documented and discussed recently (21). In concert with this, among many non-pregnant adults treated for subclinical hypothyroidism, the use of thyroid hormone therapy has not been found to be associated with improvements in general quality of life or thyroid-related symptoms (22). As the latter authors concluded, these findings did not support the routine use of thyroid hormone therapy in adults diagnosed to have subclinical hypothyroidism, i.e., to have TSH values exceeding certain cut-offs without fT4 reductions.
As long as two decades ago, Andersen et al. (23) performed a study during which they collected urine and blood samples monthly for 1 year in healthy men living in an area of mild to moderate iodine deficiency. The authors found a positive relationship between circulating TSH and the over-the-year-averaged iodine excretion rates exceeding 50 μg/day, whereas the correlation was inverse below this excretion rate, again revealing a U-shape between iodine status and TSH. Remarkably, the nadir of the later occurred at the iodine excretion level close to the UIC range with the respective lowest TSH values of those studies that reported TSH measurements for both lower and higher iodine intakes (11, 14, 16, 20, 24). Figure 1 schematically represents the potential U-shaped relationship between iodine status and related circulating TSH levels suggesting a physiological nadir of the TSH-iodine intake relationship already when iodine supply is still insufficient.
Figure 1. Schematic representation of the probable U-shaped relationship between circulating TSH and iodine nutritional status (urinary iodine, logarithmized). The filled circles show median urinary iodine measurements and related TSH values of studies describing a mild iodine deficiency along with a situation of an (at least somewhat) improved iodine supply. Open triangles show a moderate or an almost severe iodine deficiency each along with an improved iodine status. Asterisks denote studies that have provided iodine measurements not as μg/L, but as μg/day.
One reason why this “early” TSH nadir, rather occurring in the range of mild to moderate iodine deficiency has not been detected in a number of epidemiological studies may be that TSH assays with less analytical accuracy and precision could have been used (5, 25).
Although the underlying mechanisms for a reduced TSH signaling particularly during mild to moderate iodine deficiency are not yet definitely clarified, it can be assumed that the major parts of the TSH increases related to improvements in iodine nutrition are of physiological and not of pathophysiological nature. Correspondingly increased TSH values have not only been documented in specifically screened thyroid healthy children and adolescents (20), but also in thyroid healthy adults (10).
Improving iodine nutrition and thus iodine availability to the “mild-to-moderately iodine-deficient” thyroid gland will reduce mass and number of the gland's cells, of which each remaining cell consequently will require a higher TSH signal to maintain thyroid hormone adequacy. Apart from an inhibitory effect of an increased iodine level on TSH signaling within the thyroid cell, i.e., a lowered sensitivity of the gland to TSH (26), also the reduced capillary vascularization of the thyroid that is reducing in size (26), may contribute to a physiologically raised TSH requirement.
Taken together, whenever progress against iodine deficiency is seen, e.g., due to a successful salt iodization in a mild to moderate deficient area, a regular increase in the population's TSH levels should be expected and although definite proof is still lacking it may be interpreted as the gland's physiological response to an improved iodine availability. Unfortunately, corresponding TSH increases are commonly interpreted—and in a way medically “mis-termed”—as increases in the prevalence of subclinical hypothyroidism, which may have contributed to the probable over-prescription of thyroxine, recently reported (21).
Author Contributions
The author confirms being the sole contributor of this work and has approved it for publication.
Conflict of Interest
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Andersson MZMB. Thyroid function testing. In: Influence of Iodine Deficiency and Excess on Thyroid Function Tests. New York, NY: Springer (2010). p. 45–70. doi: 10.1007/978-1-4419-1485-9_3
2. Guan H, Shan Z, Teng X, Li Y, Di Teng, Jin Y, Yu X, Fan C, Chong W, Yang F, et al. Influence of iodine on the reference interval of TSH and the optimal interval of TSH: results of a follow-up study in areas with different iodine intakes. Clin Endocrinol (Oxf). (2008) 69:136–41. doi: 10.1111/j.1365-2265.2007.03150.x
3. Aakre I, Tveito Evensen L, Kjellevold M, Dahl L, Henjum S, Alexander J, et al. Iodine status and thyroid function in a group of seaweed consumers in Norway. Nutrients. (2020) 12:3483. doi: 10.3390/nu12113483
4. Markou K, Georgopoulos N, Kyriazopoulou V, Vagenakis AG. Iodine-Induced hypothyroidism. Thyroid. (2001) 11:501–10. doi: 10.1089/105072501300176462
5. Zimmermann MB, Aeberli I, Andersson M, Assey V, Yorg JAJ, Jooste P, et al. Thyroglobulin is a sensitive measure of both deficient and excess iodine intakes in children and indicates no adverse effects on thyroid function in the UIC range of 100-299 μg/L: a UNICEF/ICCIDD study group report. J Clin Endocrinol Metab. (2013) 98:1271–80. doi: 10.1210/jc.2012-3952
6. Laurberg P, Bülow Pedersen I, Knudsen N, Ovesen L, Andersen S. Environmental iodine intake affects the type of nonmalignant thyroid disease. Thyroid. (2001) 11:457–69. doi: 10.1089/105072501300176417
7. Meng F, Zhao R, Liu P, Liu L, Liu S. Assessment of iodine status in children, adults, pregnant women and lactating women in iodine-replete areas of China. PLoS ONE. (2013) 8:e81294. doi: 10.1371/journal.pone.0081294
8. Laurberg P, Bülow Pedersen I, Carlé A, Knudsen N, Andersen S, Ovesen L, Rasmussen LB. Comprehensive handbook of iodine: nutritional, biochemical, pathological and therapeutic aspects. In: The U-Shaped Curve of Iodine Intake and Thyroid Disorders. San Diego: Elsevier (2009). p. 449–57
9. Kim HI, Oh H-K, Park SY, Jang HW, Shin M-H, Kim SW, et al. Urinary iodine concentration and thyroid hormones: Korea National Health and Nutrition Examination Survey 2013-2015. Eur J Nutr. (2019) 58:233–40. doi: 10.1007/s00394-017-1587-8
10. Zhao L, Di, Teng, Shi X, Li Y, Ba J, Chen B, Du J, He L, Lai X, Li Y, et al. The Effect of increased iodine intake on serum thyrotropin: a cross-sectional, Chinese nationwide study. Thyroid. (2020) 30:1810–9. doi: 10.1089/thy.2019.0842
11. Gao TS, Teng WP, Shan ZY, Jin Y, Guan HX, Teng XC, et al. Effect of different iodine intake on schoolchildren's thyroid diseases and intelligence in rural areas. Chin Med J (Engl). (2004) 117:1518–22. doi: 10.3760/cma.j.issn.0366-6999.2004.10.115
12. Andersen S, Iversen F, Terpling S, Pedersen KM, Gustenhoff P, Laurberg P. More hypothyroidism and less hyperthyroidism with sufficient iodine nutrition compared to mild iodine deficiency–a comparative population-based study of older people. Maturitas. (2009) 64:126–31. doi: 10.1016/j.maturitas.2009.08.007
13. Tammaro A, Pigliacelli F, Fumarola A, Persechino S. Trends of thyroid function and autoimmunity to 5 years after the introduction of mandatory iodization in Italy. Eur Ann Allergy Clin Immunol. (2016) 48:77–81. Available online at: https://europepmc.org/article/med/27152602
14. Bjergved L, Jørgensen T, Perrild H, Carlé A, Cerqueira C, Krejbjerg A, et al. Predictors of change in serum TSH after iodine fortification: an 11-year follow-up to the DanThyr study. J Clin Endocrinol Metab. (2012) 97:4022–9. doi: 10.1210/jc.2012-2508
15. Szabolcs I, Podoba J, Feldkamp J, Dohan O, Farkas I, Sajgó M, et al. Comparative screening for thyroid disorders in old age in areas of iodine deficiency, long-term iodine prophylaxis and abundant iodine intake. Clin Endocrinol (Oxf). (1997) 47:87–92. doi: 10.1046/j.1365-2265.1997.2271040.x
16. Du Y, Gao Y, Meng F, Liu S, Fan Z, Wu J, et al. Iodine deficiency and excess coexist in china and induce thyroid dysfunction and disease: a cross-sectional study. PLoS ONE. (2014) 9:e111937. doi: 10.1371/journal.pone.0111937
17. Weng W, Dong M, Zhang J, Yang J, Zhang B, Zhao X, et al. PRISMA-compliant systematic review and meta-analysis of the relationship between thyroid disease and different levels of iodine intake in mainland China. Medicine (Baltimore). (2017) 96:e7279. doi: 10.1097/MD.0000000000007279
18. Li Y, Di Teng, Ba J, Chen B, Du J, He L, Lai X, Teng X, Shi X, Li Y, et al. efficacy and safety of long-term universal salt iodization on thyroid disorders: epidemiological evidence from 31 provinces of Mainland. China Thyroid. (2020) 30:568–79. doi: 10.1089/thy.2019.0067
19. Ittermann T, Khattak RM, Nauck M, Cordova CMM, Völzke H. Shift of the TSH reference range with improved iodine supply in Northeast Germany. Eur J Endocrinol. (2015) 172:261–7. doi: 10.1530/EJE-14-0898
20. Johner SA, Thamm M, Stehle P, Nöthlings U, Kriener E, Völzke H, et al. Interrelations between thyrotropin levels and iodine status in thyroid-healthy children. Thyroid. (2014) 24:1071–9. doi: 10.1089/thy.2013.0480
21. Burgos N, Toloza FJK, Singh Ospina NM, Brito JP, Salloum RG, Hassett LC, et al. Clinical outcomes after discontinuation of thyroid hormone replacement: a systematic review and meta-analysis. Thyroid. (2021) 31:740–51. doi: 10.1089/thy.2020.0679
22. Feller M, Snel M, Moutzouri E, Bauer DC, Montmollin M de, Aujesky D, et al. association of thyroid hormone therapy with quality of life and thyroid-related symptoms in patients with subclinical hypothyroidism: a systematic review and meta-analysis. JAMA. (2018) 320:1349–59. doi: 10.1001/jama.2018.13770
23. Andersen S, Pedersen KM, Pedersen IB, Laurberg P. Variations in urinary iodine excretion and thyroid function. a 1-year study in healthy men. Eur J Endocrinol. (2001) 144:461–5. doi: 10.1530/eje.0.1440461
24. van den Briel T, West CE, Hautvast JG, Vulsma T, Vijlder JJ de, Ategbo EA. Serum thyroglobulin and urinary iodine concentration are the most appropriate indicators of iodine status and thyroid function under conditions of increasing iodine supply in schoolchildren in Benin. J Nutr. (2001) 131:2701–6. doi: 10.1093/jn/131.10.2701
25. Kalaria T, Sanders A, Fenn J, Ashby HL, Mohammed P, Buch HN, et al. The diagnosis and management of subclinical hypothyroidism is assay-dependent- Implications for clinical practice. Clin Endocrinol (Oxf). (2021) 94:1012–6. doi: 10.1111/cen.14423
Keywords: iodine deficiency, iodine status, subclinical hypothyroidism, thyrotropin, TSH, thyroid gland
Citation: Remer T (2022) Why an Increase of TSH in Populations With Initially Mild-to-Moderate Iodine Deficiency Can Be Good News. Front. Nutr. 9:910160. doi: 10.3389/fnut.2022.910160
Received: 01 April 2022; Accepted: 01 June 2022;
Published: 17 June 2022.
Edited by:
Edgar Pinto, Polytechnic Institute of Porto, PortugalReviewed by:
Shariq R. Masoodi, Sher-I-Kashmir Institute of Medical Sciences, IndiaCopyright © 2022 Remer. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Thomas Remer, remer@uni-bonn.de